Загрузка...
Current management of RET rearranged non-small cell lung cancer
The identification of oncogenic drivers, and the subsequent development of targeted therapies established biomarker-based care for metastatic non-small cell lung cancer (NSCLC). Biomarker testing is standard of care in NSCLC patients with adenocarcinoma because multiple targeted therapies are availa...
Сохранить в:
| Опубликовано в: : | Ther Adv Med Oncol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385825/ https://ncbi.nlm.nih.gov/pubmed/32782485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920928634 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|